SG Americas Securities LLC Grows Position in Cabot Corporation $CBT

SG Americas Securities LLC boosted its stake in shares of Cabot Corporation (NYSE:CBT) by 260.0% in the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 36,301 shares of the specialty chemicals company’s stock after acquiring an additional 26,216 shares during the period. SG Americas Securities LLC owned 0.07% of Cabot worth $2,406,000 at the end of the most recent quarter.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Gabelli Funds LLC lifted its stake in Cabot by 1.3% in the 3rd quarter. Gabelli Funds LLC now owns 13,570 shares of the specialty chemicals company’s stock worth $1,032,000 after purchasing an additional 180 shares in the last quarter. Franklin Resources Inc. increased its holdings in shares of Cabot by 1.7% in the second quarter. Franklin Resources Inc. now owns 10,551 shares of the specialty chemicals company’s stock worth $791,000 after purchasing an additional 181 shares during the last quarter. First Citizens Bank & Trust Co. increased its holdings in shares of Cabot by 1.4% in the third quarter. First Citizens Bank & Trust Co. now owns 14,558 shares of the specialty chemicals company’s stock worth $1,107,000 after purchasing an additional 206 shares during the last quarter. M&T Bank Corp lifted its position in shares of Cabot by 1.7% in the second quarter. M&T Bank Corp now owns 16,764 shares of the specialty chemicals company’s stock worth $1,257,000 after buying an additional 276 shares in the last quarter. Finally, Hantz Financial Services Inc. boosted its stake in Cabot by 227.5% during the third quarter. Hantz Financial Services Inc. now owns 429 shares of the specialty chemicals company’s stock valued at $33,000 after buying an additional 298 shares during the last quarter. 93.18% of the stock is currently owned by institutional investors.

Cabot Price Performance

NYSE:CBT opened at $75.88 on Friday. The firm has a market capitalization of $3.96 billion, a price-to-earnings ratio of 13.29, a PEG ratio of 10.01 and a beta of 0.84. The company has a debt-to-equity ratio of 0.49, a current ratio of 1.67 and a quick ratio of 1.09. The business has a 50 day simple moving average of $73.22 and a 200-day simple moving average of $70.11. Cabot Corporation has a 1 year low of $58.33 and a 1 year high of $83.71.

Cabot (NYSE:CBT) last released its earnings results on Tuesday, February 3rd. The specialty chemicals company reported $1.53 earnings per share for the quarter, beating the consensus estimate of $1.40 by $0.13. Cabot had a return on equity of 22.82% and a net margin of 8.62%.The firm had revenue of $849.00 million for the quarter, compared to the consensus estimate of $889.11 million. During the same quarter in the previous year, the company posted $1.76 EPS. The company’s revenue for the quarter was down 11.1% compared to the same quarter last year. Cabot has set its FY 2026 guidance at 6.000-6.500 EPS. Equities analysts forecast that Cabot Corporation will post 7.57 EPS for the current year.

Cabot Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Friday, March 13th. Stockholders of record on Friday, February 27th were paid a $0.45 dividend. The ex-dividend date of this dividend was Friday, February 27th. This represents a $1.80 annualized dividend and a dividend yield of 2.4%. Cabot’s dividend payout ratio is currently 31.52%.

Analysts Set New Price Targets

A number of research firms have issued reports on CBT. Weiss Ratings reaffirmed a “hold (c-)” rating on shares of Cabot in a research note on Monday, December 29th. Zacks Research raised shares of Cabot from a “strong sell” rating to a “hold” rating in a report on Tuesday, January 27th. UBS Group boosted their price target on shares of Cabot from $74.00 to $81.00 and gave the stock a “neutral” rating in a research report on Thursday, February 5th. Mizuho set a $75.00 price target on shares of Cabot and gave the company a “neutral” rating in a research note on Wednesday, February 4th. Finally, Jefferies Financial Group reiterated a “buy” rating and set a $85.00 price objective on shares of Cabot in a research report on Wednesday, February 4th. One research analyst has rated the stock with a Buy rating, four have issued a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat.com, Cabot presently has a consensus rating of “Hold” and a consensus price target of $73.75.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.